USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Price Point Analysis for Laboratory Developed Tests (LDTs) and FDA Regulated Tests
Discover the Perfect Assay Price Point to Remain Competitive
12-Sep-2016
North America
Market Research
9AB9-00-55-00-00
HC02677-NA-MR_18988
$1,500.00
Special Price $1,125.00 save 25 %
The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therapy monitoring). A selective list of therapeutic areas covered in this research include: autoimmune diseases, cancers (breast, colorectal, prostrate, lung, gastric, cervical, and ovarian), toxicology, cardiology, women’s health (vitamin D, prenatal, pregnancy and hormone), and infectious disease testing (TB, hepatitis A/B/C, cytomegalovirus). The base year used for analysis is 2015.
Research Scope
Executive Summary
Executive Summary (continued)
Executive Summary (continued)
Research Objectives
Abbreviations
Celiac Disease Specific LDT Assays
Chron’s Disease Specific LDT Assays
Rheumatoid Arthritis Specific LDT Assays
Lupus Specific LDT Assays
LupusSpecific LDT Assays (continued)
IBD and IBS Specific LDT Assays
Biomarker Guidelines
Cardiac Disease Specific LDTs and FDA Assays
Cardiac Disease Specific LDTs and FDA Assays (continued)
Prostate Cancer Specific LDT Assays
Prostate Cancer Specific LDT Assays (continued)
Breast Cancer Specific LDT Assays
Breast Cancer Specific LDT Assays (continued)
Breast Cancer Specific LDT Assays (continued)
Colon Cancer Specific LDT and CLIA Waived Assays
Colon Cancer Specific LDT and CLIA Waived Assays (continued)
Colon Cancer Specific LDT and CLIA Waived Assays (continued)
Lung Cancer Specific LDT and FDA Assays
Lung Cancer Specific LDT and FDA Assays (continued)
Gynecologic Cancers (Ovarian)Specific LDT and FDA Assays
Gynecologic Cancers (Cervical)Specific LDT and FDA Assays
Biomarker Guidelines
Gastric Cancer/GIST Specific LDT and FDA Assays
Women’s Health Vitamin D Tests
Women’s Health Prenatal Tests
Women’s Health Pregnancy and Hormone Tests
Toxicology Popularly Ordered Tests
Infectious Diseases Popularly Ordered Genetic Tests
Infectious Diseases Popularly Ordered Tests
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related In Vitro Diagnostics (IVD) research
21 Jul 2026 | Global | Market Research
Point-of-Care Testing Market, Global, 2024–2031
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized ...
17 Jul 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Precision Diagnostics, Advanced Biologics, and Next-generation Vaccines
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age...
08 Jul 2026 | Global | Technology Research
Precision Obesity Management: AI-Guided Metabolic Modulation
The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and envir...
25 Jun 2026 | Global | Technology Research
Quantum Sensors Transitioning from Lab to Industry: Ultra-Precision Measurement for Healthcare, Defense, and Manufacturing
Quantum sensing is transitioning from laboratory research to industrial deployment, driven by the need for ultra-precise, reliable measurement in high-impact sectors such as healthcare, defense, and advanced manufacturing. This shift reflects a broader move from controlled, research-grade environmen...
22 Jun 2026 | Global | Market Research
Growth Opportunities, Global Life Sciences LIMS Market, Forecast to 2031
The global life sciences laboratory information management systems (LIMS) industry is forecast to grow from 2026 to 2031 at a CAGR of 8.5%, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions.
Leading players in the global life sciences L...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Divyaa Ravishankar |
| Industries | Healthcare |
| WIP Number | 9AB9-00-55-00-00 |
| Is Prebook | No |